{
  "id": "clinical#screening_cues_d1eb469a",
  "content": "in the use of a substance in individuals who have developed dependence on that\nsubstance, or have used the substance for a prolonged period or in large amounts.\nNote: substance withdrawal can occur when prescribed psychoactive medications (e.g.\nopioids, anxiolytics, stimulants) have been used in standard therapeutic doses.\n• The specific features of substance withdrawal depend on the pharmacological properties of\nthe specified substance (see Table 6.16, p. 484), and are consistent with those recognized as\noccurring upon cessation or reduction of the particular substance or other members of the\nsame pharmacological group of substances. The symptoms also vary in degree of severity\nand duration, depending on the substance and the amount and pattern of prior use.\n• The symptoms are not better accounted for by another medical condition or another\nmental disorder.\nNote: substance withdrawal is only applicable for some substances or substance classes (see the list\nabove and Table 6.13, p. 450). Table 6.16 (p. 484) lists the most common symptoms, behaviours\nand physiological features for each substance class.\nDiagnostic requirements for disorders due to substance use | Substance withdrawal\n480 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues in the use of a substance in individuals who have developed dependence on that\nsubstance, or have used the substance for a prolonged period or in large amounts.\nNote: substance withdrawal can occur when prescribed psychoactive medications (e.g.\nopioids, anxiolytics, stimulants) have been used in standard therapeutic doses.\n• The specific features of substance withdrawal depend on the pharmacological properties of\nthe specified substance (see Table 6.16, p. 484), and are consistent with those recognized as\noccurring upon cessation or reduction of the particular substance or other members of the\nsame pharmacological group of substances. The symptoms also vary in degree of severity\nand duration, depending on the substance and the amount and pattern of prior use.\n• The symptoms are not better accounted for by another medical condition or another\nmental disorder.\nNote: substance withdrawal is only applicable for some substances or substance classes (see the list\nabove and Table 6.13, p. 450). Table 6.16 (p. 484) lists the most common symptoms, behaviours\nand physiological features for each substance class.\nDiagnostic requirements for disorders due to substance use | Substance withdrawal\n480 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders In the use of a substance in individuals who have developed dependence on that\nsubstance, or have used the substance for a prolonged period or in large amounts. note: substance withdrawal can occur when prescribed psycho..."
}